189 related articles for article (PubMed ID: 15258995)
21. TGF-β inhibits metastasis in late stage human squamous cell carcinoma of the skin by a mechanism that does not involve Id1.
Ganapathy A; Paterson IC; Prime SS; Eveson JW; Pring M; Price N; Threadgold SP; Davies M
Cancer Lett; 2010 Dec; 298(1):107-18. PubMed ID: 20663607
[TBL] [Abstract][Full Text] [Related]
22. Blockade of transforming growth factor-beta signaling suppresses progression of androgen-independent human prostate cancer in nude mice.
Zhang F; Lee J; Lu S; Pettaway CA; Dong Z
Clin Cancer Res; 2005 Jun; 11(12):4512-20. PubMed ID: 15958637
[TBL] [Abstract][Full Text] [Related]
23. Establishment of a highly metastatic tongue squamous cell carcinoma cell line from New Zealand White rabbit.
Wulong J; Zhou L; Xiaojian Z; Jie T; Huilin G
Arch Oral Biol; 2008 Nov; 53(11):1084-90. PubMed ID: 18691699
[TBL] [Abstract][Full Text] [Related]
24. Endogenous TGF-beta1 inhibits the growth and metastatic dissemination of rat oral carcinoma cell lines but enhances local bone resorption.
Davies M; Prime SS; Stone AM; Huntley SP; Eveson JW; Paterson IC
J Oral Pathol Med; 2000 May; 29(5):232-40. PubMed ID: 10801041
[TBL] [Abstract][Full Text] [Related]
25. SCID mouse lymphogenous metastatic model of human lung cancer constructed using orthotopic inoculation of cancer cells.
Miyoshi T; Kondo K; Ishikura H; Kinoshita H; Matsumori Y; Monden Y
Anticancer Res; 2000; 20(1A):161-3. PubMed ID: 10769649
[TBL] [Abstract][Full Text] [Related]
26. A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.
Fritzmann J; Morkel M; Besser D; Budczies J; Kosel F; Brembeck FH; Stein U; Fichtner I; Schlag PM; Birchmeier W
Gastroenterology; 2009 Jul; 137(1):165-75. PubMed ID: 19328798
[TBL] [Abstract][Full Text] [Related]
27. [Expression of transforming growth factor beta(TGF-beta) subtypes in oral squamous cell carcinoma].
Jin X; Li J; Li Z; Li Y
Hua Xi Kou Qiang Yi Xue Za Zhi; 2001 Dec; 19(6):377-9. PubMed ID: 12539688
[TBL] [Abstract][Full Text] [Related]
28. Positive and negative regulation of podoplanin expression by TGF-β and histone deacetylase inhibitors in oral and pharyngeal squamous cell carcinoma cell lines.
Ohta M; Abe A; Ohno F; Hasegawa Y; Tanaka H; Maseki S; Kondo E; Kurita K; Nakanishi H
Oral Oncol; 2013 Jan; 49(1):20-6. PubMed ID: 22840788
[TBL] [Abstract][Full Text] [Related]
29. SD-208, a novel transforming growth factor beta receptor I kinase inhibitor, inhibits growth and invasiveness and enhances immunogenicity of murine and human glioma cells in vitro and in vivo.
Uhl M; Aulwurm S; Wischhusen J; Weiler M; Ma JY; Almirez R; Mangadu R; Liu YW; Platten M; Herrlinger U; Murphy A; Wong DH; Wick W; Higgins LS; Weller M
Cancer Res; 2004 Nov; 64(21):7954-61. PubMed ID: 15520202
[TBL] [Abstract][Full Text] [Related]
30. [Establishing orthotopic transplanted models of human pancreatic cancer in nude mice and study on their biological properties].
Liu QZ
Zhonghua Zhong Liu Za Zhi; 1992 Nov; 14(6):403-6. PubMed ID: 1338984
[TBL] [Abstract][Full Text] [Related]
31. Growth inhibition of BALB/c mouse keratinocytes by TGF-beta 1 and CeReS-18 appears to act through distinct mechanisms.
Betz NA; Fattaey HK; Johnson TC
Exp Cell Res; 1996 Aug; 227(1):47-54. PubMed ID: 8806450
[TBL] [Abstract][Full Text] [Related]
32. The tumor suppressor Smad4 is required for transforming growth factor beta-induced epithelial to mesenchymal transition and bone metastasis of breast cancer cells.
Deckers M; van Dinther M; Buijs J; Que I; Löwik C; van der Pluijm G; ten Dijke P
Cancer Res; 2006 Feb; 66(4):2202-9. PubMed ID: 16489022
[TBL] [Abstract][Full Text] [Related]
33. Feasibility and limits of an orthotopic human colon cancer model in nude mice.
Thalheimer A; Illert B; Bueter M; Gattenlohner S; Stehle D; Gasser M; Thiede A; Waaga-Gasser AM; Meyer D
Comp Med; 2006 Apr; 56(2):105-9. PubMed ID: 16639976
[TBL] [Abstract][Full Text] [Related]
34. Tenascin induction in tenascin nonproducing carcinoma cell lines in vivo and by TGF-beta 1 in vitro.
Sakai T; Kawakatsu H; Ohta M; Saito M
J Cell Physiol; 1994 Jun; 159(3):561-72. PubMed ID: 7514613
[TBL] [Abstract][Full Text] [Related]
35. Bone morphogenetic protein 7 in the development and treatment of bone metastases from breast cancer.
Buijs JT; Henriquez NV; van Overveld PG; van der Horst G; Que I; Schwaninger R; Rentsch C; Ten Dijke P; Cleton-Jansen AM; Driouch K; Lidereau R; Bachelier R; Vukicevic S; Clézardin P; Papapoulos SE; Cecchini MG; Löwik CW; van der Pluijm G
Cancer Res; 2007 Sep; 67(18):8742-51. PubMed ID: 17875715
[TBL] [Abstract][Full Text] [Related]
36. Attenuated type II TGF-beta receptor signalling in human malignant oral keratinocytes induces a less differentiated and more aggressive phenotype that is associated with metastatic dissemination.
Huntley SP; Davies M; Matthews JB; Thomas G; Marshall J; Robinson CM; Eveson JW; Paterson IC; Prime SS
Int J Cancer; 2004 Jun; 110(2):170-6. PubMed ID: 15069677
[TBL] [Abstract][Full Text] [Related]
37. Establishment of cervical lymph node metastasis model of squamous cell carcinoma in the oral cavity in mice.
Sun R; Zhang JG; Guo CB
Chin Med J (Engl); 2008 Oct; 121(19):1891-5. PubMed ID: 19080119
[TBL] [Abstract][Full Text] [Related]
38. Lymph node and pulmonary metastases after transplantation of oral squamous cell carcinoma cell line (HSC-3) into the subcutaneous tissue of nude mouse: detection of metastases by genetic methods using beta-globin and mutant p53 genes.
Shigeta T; Umeda M; Komatsubara H; Komori T
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Apr; 105(4):486-90. PubMed ID: 18061490
[TBL] [Abstract][Full Text] [Related]
39. Inability of transforming growth factor-beta to cause SnoN degradation leads to resistance to transforming growth factor-beta-induced growth arrest in esophageal cancer cells.
Edmiston JS; Yeudall WA; Chung TD; Lebman DA
Cancer Res; 2005 Jun; 65(11):4782-8. PubMed ID: 15930298
[TBL] [Abstract][Full Text] [Related]
40. Transforming growth factor-beta1 immobilises dendritic cells within skin tumours and facilitates tumour escape from the immune system.
Weber F; Byrne SN; Le S; Brown DA; Breit SN; Scolyer RA; Halliday GM
Cancer Immunol Immunother; 2005 Sep; 54(9):898-906. PubMed ID: 15776284
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
